首页> 外文期刊>Gastroenterologie clinique et biologique >Do patients with nonalcoholic fatty liver disease die from their heart?
【24h】

Do patients with nonalcoholic fatty liver disease die from their heart?

机译:非酒精性脂肪肝患者会死于心脏吗?

获取原文
获取原文并翻译 | 示例
           

摘要

Nonalcoholic fatty liver disease (NAFLD) has become the leading cause of chronic liver disease in Western countries [1,2]. The prevalence of the disease is as high as 70 to 80% among persons who are obese or have diabetes. NAFLD exposes to the development of fibrosis, cirrhosis and hepa-tocellular carcinoma. The paper by Targher et al. focuses on the growing evidence supporting a strong association between NAFLD and the risk of cardiovascular disease [3]. It develops and supports the hypothesis that NAFLD may be involved in the pathogenesis of cardiovascular diseases. First, the authors show that NAFLD increases the risk of cardiovascular disease. Then, they present convincing data suggesting that patients with NAFLD die from their heart much more frequently than from their liver disease. Finally, they present evidence supporting the crucial role of necroinflammatory hepatic lesions in this process.
机译:在西方国家,非酒精性脂肪性肝病(NAFLD)已成为慢性肝病的主要原因[1,2]。在肥胖或患有糖尿病的人中,该疾病的患病率高达70%至80%。 NAFLD暴露于纤维化,肝硬化和肝细胞癌的发展。 Targher等人的论文。重点关注越来越多的证据支持NAFLD与心血管疾病的风险之间有很强的联系[3]。它发展并支持NAFLD可能参与心血管疾病发病机制的假说。首先,作者表明,NAFLD增加了患心血管疾病的风险。然后,他们提供了令人信服的数据,表明NAFLD患者死于心脏的频率比死于肝病的频率更高。最后,他们提供证据支持坏死性肝损伤在此过程中的关键作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号